ヴァージニア州における妊娠死亡リスクが高い医学的に複雑な集団における妊娠の結果:遡及的観察研究
Michael J Green1, Lauren G Anderson1, Jerome J Federspiel2,3,4
1Division of Women's Community and Population Health, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA.
BMC medicine
|February 19, 2026
まとめ
何千もの個人が重度の慢性疾患や妊娠合併症に直面し,医学的に示された中絶を必要とします. 妊娠中絶へのアクセスは,州の制限にもかかわらず,生命を脅かす状態の患者にとって非常に重要です.
科学分野:
- 生殖器保健は,生殖器の健康についてです.
- 妊産婦・胎児医学について
- 公共衛生政策 公共衛生政策
背景:
- 中絶は,妊婦の死亡や重傷を防ぐために医学的に示されています.
- 米国のいくつかの州は,医学的に必要な中絶へのアクセスを制限しています.
- 妊娠中絶を必要とする状態の有病率を理解することは,害を評価する上で極めて重要です.
研究 の 目的:
- 重篤な慢性疾患や妊娠合併症の有病率を推定し,中絶に適した妊娠合併症を推定する.
- 重度の慢性疾患を有する個人の妊娠確率を決定する.
- インジケーションの有無と有無の妊娠の結果,人工中絶を含む妊娠結果を比較する.
主な方法:
- ヴァージニア州オール・ペイヤー・クレーム・データベース (2018年−2019年) を使用した遡及的観察研究.
- 14歳から55歳までの女性患者1,502,965人を含め,6ヶ月以上保険に加入していた.
- 医療コードを用いた症状や合併症を特定し,アルゴリズムを用いた結果分類.
主要な成果:
- 生殖年齢の個人の2.9%は,妊娠中に生命を脅かす慢性疾患を持っていた.
- 妊娠中の女性の5.6%が,妊娠3ヶ月前に生命を脅かす合併症を経験しました.
- 重篤な状態や早期合併症の妊娠は,生児が少なく, spontaneous/induced abortが多くなっていました.
結論:
- 中絶制限のある州で何千人もの患者が,医学的に示された中絶を必要とする状態を経験しています.
- これは,患者の安全のために中絶へのアクセスを継続する必要性を強調しています.
- 請求データにおける人工妊娠中絶の不十分な確認は,報告の潜在的ギャップを示唆しています.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
432
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
432
Infertility in Females
4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Birth Control Methods
6.9K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
6.9K
Intrauterine Drug Delivery Systems
33
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
33
Infertility in Males
599
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
599
Teratogenicity
4.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K


